Pharmaceuticals

Ironwood Pharmaceuticals Prices Public Offering of Common Stock

9 Feb 2012

Ironwood Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 5,250,000 shares of its Class A common stock at a price of $15.09 per share to the public.

Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Leerink Swann 2012 Global Healthcare Conference on ...

9 Feb 2012

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX - News), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally ...

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results

9 Feb 2012

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year 2011, and